Listen Now

Topics Covered

  • Overview of Waldenstrom’s Macroglobulinemia
  • Symptoms & Signs
  • Front Line Treatment for WM
  • Treatment for Relapsed/Refractory WM
  • Standard of Care & New Treatment Approaches
  • Translating Genomic Findings into New Treatment Opportunities for WM
  • The Role of Clinical Trials
  • Symptom & Side Effect Management, including Reducing Complications
  • Peripheral Neuropathy
  • Communicating with Your Health Care Team about Your Quality-of-Life
  • Mapping the Future of WM
  • Questions for Our Panel of Experts

Our Panel of Experts

Jorge J. Castillo, MD

Clinical Director, Bing Center for Waldenstrom’s Macroglobulinemia, Dana-Farber Cancer Institute, Assistant Professor of Medicine, Harvard Medical School

Morie A. Gertz, MD, MACP

Consultant, Division of Hematology, Bone Marrow Transplant Program, Chair Emeritus Internal Medicine, Roland Seidler Jr. Professor Department of Medicine, College of Medicine, Mayo Distinguished Clinician, Mayo Clinic Rochester

Carl Harrington

President, IWMF - The International Waldenstrom’s Macroglobulinemia Foundation

Caroline Edlund, MSW

Online Support Group Program Director, CancerCare


You can download the brochure for this workshop(pdf)(176 KB)

Workshop Date

This workshop was originally recorded on June 27, 2018.

Browse by Diagnosis

Browse by Topic

The information presented in this workshop is provided for your general information only. It is not intended as medical advice and should not be relied upon as a substitute for consultations with qualified health professionals who are aware of your specific situation. We encourage you to take information and questions back to your individual health care provider as a way of creating a dialogue and partnership about your cancer and your treatment.

Back to Top
Terms of Use and Privacy Policy

By using our website, you agree to our recently updated Privacy Policy . Here you can read more about our use of cookies which help us make continuous improvements to our website. Privacy Policy.